Management Of Menopausal Complaints, Mild Hypertension, Acidity, Low Immunity , Border Line Cholesterol And Obesity Using The 'integrated Approach' In A Patient With History Of Ovarian Cancer


Affiliations

  • Founder Director, Health Total Pvt. Ltd., Nutritionist, Researcher, Columnist,, India

Abstract

A 43-year-old female was diagnosed with ovarian cancer in the year 2000, following which a hysterectomy was performed in the year 2010. After the surgery, the patient received six cycles of conventional chemotherapy treatment in 2010. She presented at the Health Total centre in January 2017. Her height was 5' 1" and w eight 72.8 kg, yielding a body mass index (BM I) o f 30.3 k g /m ;, which reflected obesity. She also suffered from menopausal com plaints, mild hypertension, depression, acidity, stress, low immunity, along with borderline cholesterol. This case study illustrates the benefits of the 'Integrated Approach' in the management of obesity, hypercholesterolemia, along with improvement in immunity, energy, acidity, depression and reduction in menopausal com plaints. The Integrated Approach included patient-specific nutrition a l therapy, ayurvedic herb support, vitamin and dietary supplements, stress management and regular exercise. A healthy diet and lifestyle modifications play a significant role in w eight loss in obese individuals, m ore specifically in individuals with a history of carcinomas. During the 25-week treatment period, the patient achieved significant w eight loss with subsequent improvement in acidity along with reduced stress levels, increased immunity, thus showing significant improvement in the quality of life of the patient.

Keywords

Obesity, Immunity, Menopausal complaints, Integrated Approach, Nutrition, Ayurveda

Full Text:

References

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality World wide: IARC Cancer Base No. 10 [Internet], Lyon, France:

International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr

Olsen CM, Green AC, Whitem an DC, et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta analysis. Eur J Cancer. 2007.43(4):690-709.

Kang DH, Weaver MT, Park NJ, Smith B, Mc Ardle T, Carpenteri. Significant Impirment in Immune Recovery Following Cancer Treatment. Nurs Res. 2009. 58(2): 105 114.

Saeaib N, Peeyananjarassri K, Liabsuetrakul T, Buhachat R, Myriokefalitaki E. Hormone replacement therapy after surgery for

epithelial ovarian cancer. Cochrane Database o f Systematic Reviews. 2017, Issue 2. A rt. No.: CD0125S9. DOI: 10.1002/14651858.CD012559.

Gogoi A, Gogoi N, Neog B. Dubious Anti-obesityaent HCA from Garcinia ; Asystem atic review. Int J Pharm Pharm Sci.

.7(7):1-8.

Padavi DM, Rathod A, Chavhan S. Single. Drug Treatment for Chronic Kidney Disease. A Case Study. International Journal of

Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2014. 3(1): 213-218.

Bhattacharjee R, Sil PC. Protein isolate from the herb, Phyllanthus niruri, protects liver from acetaminophen induced toxicity. Biom edical Research. 2006.17(1): 75-79.

Kamath AB, W ang L, Das H, Li L, Reinhold VN, Bukowski JF. Antigens in tea-beverage prime human Vy2V2liT cells in vitro and in vivo for memory and non-memory antibacterial cytokine responses. PNAS. 2003. 100(10): 6009-6014.

Sharma K, Sharma P, Srivastav R, Srivastava A, Sharma D. Pharm acological study of Amalaki with special reference to its

antimicrobial action. International Journal of Ayurveda and Pharma Research. 2017. 5(5): 93-96.

Clark CD, Bassett B, Burge MR. Effects of kelp supplementation on thyroid function in euthyroid subjects. Endocr Pract. 2003.

(5):363-369.

Yadav B, Keshipeddi SR, Bhat S, Singh M. A perspective study of Haritaki. Int J Res Ayurveda Pharm. 2011.2:1466-1470.

Gupta SK, Sharma A. Medicinal properties of Zingiber officinal e Roscoe - A Review. Journal of Pharmacy and Biological Sciences. 2014. 9(5): 124-129.

Fock KM, Khoo J. Diet and exercise in management of obesity and overweight. Journal of Gastroenterology and

Hepatology. 2013; 28 (Suppl. 4): 59-63.


Refbacks

  • There are currently no refbacks.